Back to search
Auto-Immune Diseases
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Auto-Immune Diseases trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Auto-Immune Diseases trials you may qualify forBackground: Most people with tuberculosis (TB) feel better after starting treatment. But for some people, the opposite happens. They may feel better at first,…
This study is a prospective single-arm open-label clinical trial, including dose escalation and expansion phase, aims to evaluate the safety, efficacy, and cell…
The pathophysiology of certain inflammatory arthritides remains poorly understood, particularly when associated with rare systemic autoimmune diseases such as s…
to evaluate the safety and efficacy of GR1803 in the treatment of patients with systemic lupus erythematosus
A Phase 1 dose-escalation study designed to evaluate the safety, tolerability, and preliminary efficacy of anito-cel in subjects with generalized myasthenia gra…
Immune thrombocytopenia (ITP) is an autoimmune disease but, paradoxically, and unlike other autoimmune diseases, antiplatelet antibodies are not used either for…
This is an open-label, three-part study to assess the pharmacokinetics (PK) and pharmacodynamics (PD) of epinephrine administered as a single dose of L-dipivefr…
The incidence of autoimmune diseases (celiac disease, type 1 diabetes, thyroid disease) have increased over the past 30 years. Although most autoimmune diseases…
The standard of care therapy for DLBCL in the relapsed setting is RICE with the plan for the patient to proceed to transplant. This protocol will add Revlimid t…